Evaluation of ICA512As in combination with other islet cell autoantibodies at the onset of IDDM

Diabetes Care

Volumn 20, Issue 9, 1997, Pages 1403-1407

  Feeney, Sandra J ^a   Myers, Mark A ^a   Mackay, Ian R ^a   Zimmet, Paul Z ^a,b   Howard, Neville ^c   Verge, Charles F ^d   Rowley, Merrill J ^a  

^a MONASH UNIVERSITY   (Australia)

^b BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^c CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^d SYDNEY CHILDREN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; INSULIN; PANCREAS ISLET CELL ANTIBODY; PROTEIN TYROSINE PHOSPHATASE;

ADOLESCENT; ARTICLE; AUTOIMMUNITY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; ONSET AGE; PANCREAS ISLET; SCHOOL CHILD; SCREENING;

EID: 0030747073     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.20.9.1403     Document Type: Article

References (26)

1. Bottazzo GF, Florin-Christensen A, Doniach D: Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. Lancet ii: 1279-1283, 1974
2. Rabin DU, Pleasic SM, Shapiro JA, Yoo-Warren H, Oles J, Hicks JM, Goldstein DE, Rae PMM: Islet cell antigen 512 is a diabetes-specific autoantigen related to protein tyrosine phosphatases. J Immunol 152: 3183-3188, 1994
3. Bonifacio E, Lampasona V, Genovese S, Ferrari M, Bosi E: Identification of protein tyrosine phosphatase-like IA2 (islet cell antigen 512) as the insulin-dependent diabetes-related 37/40K autoantigen and a target of islet-cell antibodies. J Immunol 155:5419-5426, 1995
4. Notkins AL, Lu J, Li Q, VanderVegt FP, Wasserfall C, Maclaren NK, Lan MS: IA-2 and IA-2b are major autoantigens in IDDM and the precursors of the 40 kDa and 37 kDa tryptic fragments. J Autoimmun 9: 677-682, 1996
5. Baekkeskov S, Aanstoot HJ, Christgau S, Reetz A, Solimena M, Cascalho M, Folli F, Richter-Olesen H, DeCamilli P: Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature 347:151-156, 1990
6. Palmer JP: Insulin autoantibodies: their role in the pathogenesis of IDDM. Diabetes Metab Rev 3:1005-1015, 1987
7. Atkinson MA, Kaufman DL, Newman D, Tobin AJ, Maclaren NK: Islet cell cytoplasmic autoantibody reactivity to glutamate decarboxylase in insulin-dependent diabetes. J Clin Invest 9:1350-1356, 1993
8. Myers MA, Rabin DU, Rowley MJ: Pancreatic islet cell cytoplasmic antibody (ICA) in diabetes mellitus is represented by antibodies to islet cell antigen 512 and glutamic acid decarboxylase. Diabetes 44:1290-1295, 1995
9. Lan MS, Wasserfall NK, Maclaren NK, Notkins AL: IA-2, a transmembrane protein of the protein tyrosine phosphatase family, is a major autoantigen in insulin-dependent diabetes mellitus. Proc Natl Acad Sci USA 93:63-67, 1996
10. Dotta F, Gianani R, Previti M, Lenti L, Dionisi S, D'Erme M, Eisenbarth GS, Di Mario U: Autoimmunity to the GM2-1 islet ganglioside before and at the onset of type I diabetes. Diabetes 45:1193-1196, 1996
11. Tuomilehto J, Zimmet F; Mackay IR, Koskela P, Vidgren G, Toivanen L, Tuomilehto-Wolf E, Kohtamaki K, Stengard J, Rowley MJ: Antibodies to glutamic acid decarboxylase as predictors of insulin-dependent diabetes mellitus before clinical onset of disease. Lancet 343:1383-1385, 1994
12. Gleichmann H, Zorcher B, Greulich B, Cries FA, Henrichs HR, Betrams J, Kolb H: Correlation of islet cell antibodies and HLA-DR phenotypes with diabetes mellitus in adults. Diabetologia 27:90-92, 1984
13. Verge CF, Howard NJ, Rowley MJ, Mackay IR, Zimmet PZ, Egan M, Hulinska H, Hulinsky I, Silvestrini RA, Kamath S, Sharp A, Arundel T, Silink M: Anti-glutamate decarboxylase and other antibodies at the onset of childhood IDDM: a population-based study. Diabetologia 37:1113-1120, 1994
14. Rowley MJ, Mackay IR, Chen QY, Knowles WJ, Zimmet PZ: Antibodies to glutamic acid decarboxylase discriminate major types of diabetes mellitus. Diabetes 41: 548-551, 1992
15. Rabin DU, Pleasic SM, Palmer-Crocker R, Shapiro JA: Cloning and expression of IDDM-specific human autoantigens. Diabetes 41:183-186, 1995
16. Gianani R, Rabin DU, Verge CF, Yu L, Babu SR, Pietropaolo M, Eisenbarth GS: ICA512 autoantibody radioassay. Diabetes 44:1340-1344, 1995
17. Chaillous L, Delamaire M, Martignat L, Maugendre D, Marre M, Mathieu E, Limal JM, Charbonnel B, Allannic H, Sai P: Combined analysis of islet cell antibodies that cross-react with mouse pancreas, antibodies to the M(r) 64,000 islet protein, and antibodies to glutamate decarboxylase in type I diabetic patients. Diabetes Care 17:1115-1123, 1994
18. Bonifacio E, Genovese S, Braghi S, Bazzigaluppi E, Lampasona V Bingley PJ, Rogge L, Pastore MR, Bognetti E, Bottazzo GE, Gale EAM, Bosi E: Islet autoantibody markers in IDDM: risk assessment strategies yielding high sensitivity. Diabetologia 38:816-822, 1995
19. Seissler J, Morgenthaler NG, Achenbach P, Lampeter EE, Glawe D, Payton M, Christie M, Scherbaum WA: Combined screening for autoantibodies to IA-2 and antibodies to glutamic acid decarboxylase in first degree relatives of patients with IDDM. Diabetologia 39:1351-1356, 1996
20. Verge CF, Gianani R, Kawasaki E, Yu LP, Pietropaolo F Chase HP, Eisenbarth GS: Number of autoantibodies (against insulin, GAD or ICA512/IA-2) rather than particular autoantibody specificities determines risk of type 1 diabetes. J Autoimmun 9:379-383, 1996
21. Gorus FK, Goubert P, Semakula C, Vandewalle CL, De Schepper J, Scheen A, Christie MR, Pipeleers DG: IA-2-autoantibodies complement GAD65-autoantibodies in new-onset IDDM patients and help predict impending diabetes in their siblings. Diabetologia 40:95-99, 1997
22. Christie MR, Daneman D, Champagne P, Delovitch TL: Persistence of serum antibodies to 64,000-Mr islet cell protein after onset of type 1 diabetes. Diabetes 39:653-656, 1990
23. Whittingham S, Byron SL, Tuomilehto J, Zimmet PZ, Myers MA, Vidgren G, Rowley MJ, Feeney SJ, Koskela P, Tuomilehto-Wolf E, Mackay IR: Autoantibodies associated with presymptomatic insulin-dependent diabetes mellitus in women. Diabet Med. In press
24. Verge CF, Gianani R, Kawasaki E, Yu L, Pietropaolo M, Jackson RA, Chase HP Eisenbarth GS: Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies. Diabetes 45:926-933, 1996
25. Bingley PJ, Christie MR, Bonifacio E, Bonfanti R, Shattock M, Fonte MT, Bottazzo GF, Gale EA: Combined analysis of autoantibodies improves prediction of IDDM in islet cell antibody-positive relatives. Diabetes 43:1304-1310, 1994
26. Marshall MO, Hoyer PE, Petersen JS, Hejnaes KR, Genovese S, Dyrberg T, Bottazzo GF: Contribution of glutamate decarboxylase antibodies to the reactivity of islet cell cytoplasmic antibodies. J Autoimmun 7:497-508, 1994